OVATF
Price
$0.02
Change
-$0.02 (-50.00%)
Updated
Aug 26 closing price
Capitalization
1.28M
RAFA
Price
$0.09
Change
+$0.01 (+12.50%)
Updated
Sep 3 closing price
Capitalization
8.17M
Interact to see
Advertisement

OVATF vs RAFA

Header iconOVATF vs RAFA Comparison
Open Charts OVATF vs RAFABanner chart's image
Ovation Science
Price$0.02
Change-$0.02 (-50.00%)
Volume$500
Capitalization1.28M
Rafarma Pharmaceuticals, Inc. (WY)
Price$0.09
Change+$0.01 (+12.50%)
Volume$25.5K
Capitalization8.17M
OVATF vs RAFA Comparison Chart in %
Loading...
OVATF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RAFA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
OVATF vs. RAFA commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OVATF is a Hold and RAFA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 08, 2025
Stock price -- (OVATF: $0.02 vs. RAFA: $0.09)
Brand notoriety: OVATF and RAFA are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: OVATF: 6% vs. RAFA: 64%
Market capitalization -- OVATF: $1.28M vs. RAFA: $8.17M
OVATF [@Pharmaceuticals: Generic] is valued at $1.28M. RAFA’s [@Pharmaceuticals: Generic] market capitalization is $8.17M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $67.95B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.93B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

OVATF’s FA Score shows that 0 FA rating(s) are green whileRAFA’s FA Score has 2 green FA rating(s).

  • OVATF’s FA Score: 0 green, 5 red.
  • RAFA’s FA Score: 2 green, 3 red.
According to our system of comparison, RAFA is a better buy in the long-term than OVATF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

OVATF’s TA Score shows that 0 TA indicator(s) are bullish while RAFA’s TA Score has 6 bullish TA indicator(s).

  • OVATF’s TA Score: 0 bullish, 2 bearish.
  • RAFA’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, RAFA is a better buy in the short-term than OVATF.

Price Growth

OVATF (@Pharmaceuticals: Generic) experienced а 0.00% price change this week, while RAFA (@Pharmaceuticals: Generic) price change was +42.05% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -0.10%. For the same industry, the average monthly price growth was +9.00%, and the average quarterly price growth was +87.12%.

Industries' Descriptions

@Pharmaceuticals: Generic (-0.10% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RAFA($8.17M) has a higher market cap than OVATF($1.28M). RAFA YTD gains are higher at: 20.440 vs. OVATF (-38.250).
OVATFRAFAOVATF / RAFA
Capitalization1.28M8.17M16%
EBITDA-339.46KN/A-
Gain YTD-38.25020.440-187%
P/E RatioN/AN/A-
Revenue90.3KN/A-
Total Cash10.2KN/A-
Total Debt284KN/A-
FUNDAMENTALS RATINGS
OVATF vs RAFA: Fundamental Ratings
OVATF
RAFA
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
62
Fair valued
70
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
1003
PRICE GROWTH RATING
1..100
9543
P/E GROWTH RATING
1..100
1002
SEASONALITY SCORE
1..100
6550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

OVATF's Valuation (62) in the null industry is in the same range as RAFA (70). This means that OVATF’s stock grew similarly to RAFA’s over the last 12 months.

OVATF's Profit vs Risk Rating (100) in the null industry is in the same range as RAFA (100). This means that OVATF’s stock grew similarly to RAFA’s over the last 12 months.

RAFA's SMR Rating (3) in the null industry is significantly better than the same rating for OVATF (100). This means that RAFA’s stock grew significantly faster than OVATF’s over the last 12 months.

RAFA's Price Growth Rating (43) in the null industry is somewhat better than the same rating for OVATF (95). This means that RAFA’s stock grew somewhat faster than OVATF’s over the last 12 months.

RAFA's P/E Growth Rating (2) in the null industry is significantly better than the same rating for OVATF (100). This means that RAFA’s stock grew significantly faster than OVATF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
OVATFRAFA
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
N/A
Bearish Trend 4 days ago
90%
Momentum
ODDS (%)
Bearish Trend 4 days ago
59%
Bullish Trend 4 days ago
82%
MACD
ODDS (%)
Bearish Trend 4 days ago
55%
Bullish Trend 4 days ago
86%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
46%
Bullish Trend 4 days ago
69%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
46%
Bullish Trend 4 days ago
67%
Advances
ODDS (%)
N/A
Bullish Trend 6 days ago
75%
Declines
ODDS (%)
N/A
Bearish Trend 18 days ago
90%
BollingerBands
ODDS (%)
N/A
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
N/A
Bullish Trend 4 days ago
58%
View a ticker or compare two or three
Interact to see
Advertisement
OVATF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RAFA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GOOS13.390.27
+2.06%
Canada Goose Holdings
UIS3.880.06
+1.57%
Unisys Corp
URBN70.77-0.58
-0.81%
Urban Outfitters
UL64.31-0.70
-1.08%
Unilever plc
ESLA1.05-0.03
-2.78%
Estrella Immunopharma

OVATF and

Correlation & Price change

A.I.dvisor tells us that OVATF and KHTRF have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that OVATF and KHTRF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OVATF
1D Price
Change %
OVATF100%
N/A
KHTRF - OVATF
25%
Poorly correlated
N/A
KKPCF - OVATF
24%
Poorly correlated
N/A
BSPK - OVATF
20%
Poorly correlated
-5.08%
NPPNY - OVATF
9%
Poorly correlated
N/A
PCLOF - OVATF
5%
Poorly correlated
+5.13%
More

RAFA and

Correlation & Price change

A.I.dvisor tells us that RAFA and UPC have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RAFA and UPC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RAFA
1D Price
Change %
RAFA100%
N/A
UPC - RAFA
22%
Poorly correlated
-4.83%
OWPC - RAFA
7%
Poorly correlated
-0.25%
PCLOF - RAFA
6%
Poorly correlated
+5.13%
OVATF - RAFA
2%
Poorly correlated
N/A
OILFF - RAFA
2%
Poorly correlated
-10.49%
More